UK company record
Crescendo Biologics
Antibody therapeutics (Humabody platform)
CandidateCore UK
Snapshot
- UK location
- Cambridge · East of England
- Sector
- Biotech & techbio
- Latest recorded round
- Series C/D (letter unconfirmed)
- Latest recorded amount
- $32M (tranche; total raised to date $274M)
- Date
- 2023-01-01
Legal-identity layer
Candidate identity.
- Selected legal name
- CRESCENDO BIOLOGICS LIMITED
- Company number
- 06425006
- Companies House status
- active
- Incorporated
- 2007-11-13
Investors
- Andera PartnersParticipant
- BioNTechParticipant
- IP GroupParticipant
- Kreos CapitalParticipant
- Quan CapitalParticipant
- Sofinnova PartnersParticipant
- TakedaParticipant
Current directors and active controllers
- IP2IPO SERVICES LTDCurrent director
- SEGHEZZI, GrazianoCurrent director
- WILSON, StephanieCurrent director
- WU, Marietta, DrCurrent director
- AITUA LIMITEDcorporate-director
- BETTISON, Amanda Janesecretary
- BETTISON, Amanda Janesecretary
- BRADSHAW, Johnsecretary
- BRADSHAW, Johndirector
- BROWN, David, Drdirector
- COPAS, Ameliasecretary
- COULTER, Eva-Lottadirector
- DIX, Clive James, Drdirector
- GOODMAN, Alan Gilbertdirector
- HAROLD, Theodorasecretary
- HAROLD, Theodoradirector
- HONE, Graham Angussecretary
- JOHNSON, Kevin Stuart, Drdirector
- MATUSHANSKY, Igor, Drdirector
- MINSHULL BEECH, Catherine Susan, Drdirector
- NOBECOURT, Gillesdirector
- PACK, Peter, Drdirector
- REYNOLDS, Brenda Elizabethsecretary
- ROMANOS, Michael Anthony, Drdirector
- WAKELAM, Michael John Owen, Professordirector
- WOODMAN, Robbiedirector
Funding rows
- Series C/D (letter unconfirmed)$32M (tranche; total raised to date $274M) · 2023-01-01